In agreement of the above and for the first time in NSCLC, our in vitro findings demonstrate that GH stimulation increases proliferation, migration, and invasion of the tumor cells, while pharmacological inhibition of GHR signaling with pegvisomant markedly attenuates these effects in NSCLC. The gene discussed is GHR; the disease is neoplasm.